Cronos Group INC 8-K filings

Cronos Group Inc. has amended its prior filing to confirm that future advisory votes on executive compensation will be held annually, aligning with shareholder preference.

Cronos Group Inc. announced record net revenue, gross profit, and Adjusted EBITDA for Q2 2026, driven by strong performance in Canada, Israel, and Germany, alongside a significant share repurchase program.

Cronos Group reported a 40% year-over-year increase in Q1 2026 net revenue to $45.2 million, driven by strong performance in Israel and Canada, while the acquisition of CanAdelaar B.V. has been extended to September 9, 2026.

Cronos Group announced record net revenue, gross profit, and Adjusted EBITDA for Q4 and full-year 2025, driven by strong brand performance and international market growth.

Cronos Group Inc. is set to acquire CanAdelaar B.V., the largest licensed cannabis producer in the Netherlands' adult-use pilot program, for an upfront cash consideration of €57.5 million plus earnouts.

Cronos Group Inc. announced record consolidated net revenue, gross profit, and Adjusted EBITDA for its third quarter ended September 30, 2025, driven by strong international performance.

Cronos Group Inc. announced the immediate termination of its Vice President, Controller and Principal Accounting Officer, Lloyd Wilson, for cause.

Cronos Group Inc. announced a 21% year-over-year net revenue increase and positive Adjusted EBITDA for Q2 2025, driven by international and Israeli market strength.

Cronos Group Inc. announced that all proposals, including the election of directors, approval of executive compensation, and appointment of auditors, were approved by shareholders at its 2025 Annual Meeting.

Cronos Group announces a 28% year-over-year increase in net revenue for Q1 2025, fueled by strong international performance and strategic initiatives, alongside a $50 million share repurchase program.

Cronos Group Inc. announced the appointment of Anna Shlimak as its new Chief Financial Officer, effective March 19, 2025, succeeding James Holm, who will remain with the company through April 18, 2025.

Cronos Group announces a 27% increase in Q4 2024 net revenue and a 35% increase in full-year 2024 net revenue, driven by strong performance in the Canadian and Israeli cannabis markets.

Cronos Group's Q3 2024 results show a significant 38% year-over-year increase in net revenue, reaching $34.3 million, driven by strong performance in the Canadian and international markets.

Cronos Group achieved its highest quarterly net revenue on record at $27.8 million, a 46% increase year-over-year, driven by growth in Canada, Israel, Germany, and the UK.

Cronos Group Inc. has reported the final results of the shareholder vote from its reconvened 2024 Annual Meeting, including the appointment of Davidson & Company LLP as the independent auditor for fiscal year 2024.

Cronos Group's subsidiary, Peace Naturals Project Inc., has entered into an amended credit agreement, increasing its borrowing capacity by C$70 million to fund the expansion of its cannabis facility.

Cronos Group Inc. held its 2024 Annual Meeting of Shareholders on June 20, 2024, where directors were elected and executive compensation was approved, but the meeting was adjourned to finalize the appointment of a successor auditor.

Cronos Group Inc. has terminated its sale and leaseback agreement for the Peace Naturals Campus after the buyer failed to meet financing and due diligence conditions.

Cronos Group's first quarter of 2024 saw a 30% year-over-year increase in net revenue, reaching $25.3 million, driven by growth in Canada and Israel.

Cronos Group and Altria Group have entered into a voting agreement ensuring Altria's support for Cronos's proposals at the upcoming 2024 annual meeting.

KPMG will not seek re-appointment as Cronos Group's auditor due to its decision to cease providing audit services to cannabis companies, prompting Cronos to begin the search for a new auditor.

Cronos Group Inc. has announced that Ran Gorelik will transition to Chairman of Cronos Israel, and Adam Wagner will become Senior Vice President, Head of Cronos Israel, effective April 2, 2024.

Cronos Group's 2023 results show increased revenue and cost savings, but also challenges in Israel and a net loss, while the company focuses on international expansion and brand growth.